<H1>Chapter DOI: 10.1007/978-1-60327-931-4_3<br/>Cited-By Count: 2</H1><table border="1" width="30%"><tr><td>Total References</td><td>44</td></tr><tr><td>Springer references</td><td>1</td></tr><tr><td>Non Springer references</td><td>43</td></tr><tr><td>BibStructured Count</td><td width="10%">44</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>40</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>2</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>2</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>2</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>2</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1_3</td><td>BibArticle</td><td>Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, Sasai Y. (2000). Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron <Emphasis>28</Emphasis>:31&#8211;40.</td><td><a href=http://dx.doi.org/10.1016/S0896-6273(00)00083-0>10.1016/S0896-6273(00)00083-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2_3</td><td>BibArticle</td><td>Lee S-H, Lumelsky N, Studer L, Auerbach JM, McKay R. (2000). Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nature Biotechnology <Emphasis Type="Bold">18</Emphasis>:675&#8211;9.</td><td><a href=http://dx.doi.org/10.1038/76536>10.1038/76536</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3_3</td><td>BibArticle</td><td>Okabe S, Forsberg-Nilsson K, Spiro AC, Segal M, McKay RDG. (1996). Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mechanisms of Development <Emphasis Type="Bold">59</Emphasis>:89&#8211;102.</td><td><a href=http://dx.doi.org/10.1016/0925-4773(96)00572-2>10.1016/0925-4773(96)00572-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4_3</td><td>BibArticle</td><td>Rolletschek A, Chang H, Guan KM, Czyz J, Meyer M, Wobus AM. (2001). Differentia-tion of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promo-ting factors. Mechanisms of Development <Emphasis Type="Bold">105</Emphasis>:93&#8211;104.</td><td><a href=http://dx.doi.org/10.1016/S0925-4773(01)00385-9>10.1016/S0925-4773(01)00385-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5_3</td><td>BibArticle</td><td>Chung S, Sonntag KC, Andersson T, Bjorklund LM, Park JJ, Kim DW, Kang UJ, Isacson O, Kim KS. (2002). Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. European Journal of Neuroscience <Emphasis Type="Bold">16</Emphasis>:1829&#8211;38.</td><td><a href=http://dx.doi.org/10.1046/j.1460-9568.2002.02255.x>10.1046/j.1460-9568.2002.02255.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6_3</td><td>BibArticle</td><td>Grothe C, Timmer M, Scholz T, Winkler C, Nikkhah G, Claus P, Itoh N, Arenas E. (2004). Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons. Neurobiology of Disease <Emphasis Type="Bold">17</Emphasis>:163&#8211;70.</td><td><a href=http://dx.doi.org/10.1016/j.nbd.2004.07.007>10.1016/j.nbd.2004.07.007</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7_3</td><td>BibArticle</td><td>Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sanchez-Pernaute R, et al. (2002). Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson&#8217;s disease. Nature <Emphasis Type="Bold">418</Emphasis>:50&#8211;6.</td><td><a href=http://dx.doi.org/10.1038/nature00900>10.1038/nature00900</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8_3</td><td>BibArticle</td><td>Kim JY, Koh HC, Lee JY, Chang MY, Kim YC, Chung HY, Son H, Lee YS, Studer L, et al. (2003). Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression. Journal of Neurochemistry <Emphasis Type="Bold">85</Emphasis>:1443&#8211;54.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.2003.01780.x>10.1046/j.1471-4159.2003.01780.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9_3</td><td>BibArticle</td><td>Wagner J, Akerud P, Castro DS, Holm PC, Canals JM, Snyder EY, Perlmann T, Arenas E. (1999). Induction of a midbrain dopaminergic phenotype in Nurr1- overexpressing neural stem cells by type 1 astrocytes. Nature Biotechnology <Emphasis Type="Bold">17</Emphasis>:653&#8211;9.</td><td><a href=http://dx.doi.org/10.1038/10862>10.1038/10862</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10_3</td><td>BibArticle</td><td>Rodriguez-Gomez JA, Lu JQ, Velasco I, Rivera S, Zoghbi SS, Liow JS, Musachio JL, Chin FT, Toyama H, et al. (2007). Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells <Emphasis Type="Bold">25</Emphasis>:918&#8211;28.</td><td><a href=http://dx.doi.org/10.1634/stemcells.2006-0386>10.1634/stemcells.2006-0386</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11_3</td><td>BibArticle</td><td>Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA. (2006). Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nature Medicine <Emphasis Type="Bold">12</Emphasis>:1259&#8211;68.</td><td><a href=http://dx.doi.org/10.1038/nm1495>10.1038/nm1495</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12_3</td><td>BibArticle</td><td>Christophersen NS, Brundin P. (2007). Large stem cell grafts could lead to erroneous interpretations of behavioral results?. Nature Medi-cine <Emphasis Type="Bold">13</Emphasis>:118; author reply 119.</td><td><a href=http://dx.doi.org/10.1038/nm0207-118a>10.1038/nm0207-118a</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13_3</td><td>BibArticle</td><td>Bouhon IA, Kato H, Chandran S, Allen ND. (2005). Neural differentiation of mouse embryonic stem cells in chemically defined medium. Brain Research Bulletin 15 <Emphasis Type="Bold">68</Emphasis>:62&#8211;75.</td><td><a href=http://dx.doi.org/10.1016/j.brainresbull.2005.08.022>10.1016/j.brainresbull.2005.08.022</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14_3</td><td>BibArticle</td><td>Bouhon IA, Joannides A, Kato H, Chandran S, Allen ND. (2006). Embryonic stem cell-derived neural progenitors display temporal restriction to neural patterning. Stem Cells <Emphasis Type="Bold">24</Emphasis>:1908&#8211;13.</td><td><a href=http://dx.doi.org/10.1634/stemcells.2006-0031>10.1634/stemcells.2006-0031</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15_3</td><td>BibArticle</td><td>Bjorklund LM, S&#194;nchez-Pernaute R, Chung S, Andersson T, Ching Chen IY, McNaught KSP, Brownell AL, Jenkins BG, Wahlested C, et al. (2002). Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proceedings of National Academy of Science USA <Emphasis Type="Bold">99</Emphasis>:2344&#8211;9.</td><td><a href=http://dx.doi.org/10.1073/pnas.022438099>10.1073/pnas.022438099</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16_3</td><td>BibArticle</td><td>Fareed MU, Moolten FL. (2002). Suicide gene transduction sensitizes murine embryonic and human mesenchymal stem cells to ablation on demand &#8211; A fail-safe protection against cellular misbehavior. Gene Therapy <Emphasis Type="Bold">9</Emphasis>:955&#8211;62.</td><td><a href=http://dx.doi.org/10.1038/sj.gt.3301771>10.1038/sj.gt.3301771</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17_3</td><td>BibArticle</td><td>Schuldiner M, Itskovitz-Eldor J, Benvenisty N. (2003). Selective ablation of human embryonic stem cells expressing a &#8220;suicide&#8221; gene. Stem Cells<Emphasis Type="Bold">21</Emphasis>:257&#8211;65.</td><td><a href=http://dx.doi.org/10.1634/stemcells.21-3-257>10.1634/stemcells.21-3-257</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18_3</td><td>BibArticle</td><td>Thakahashi K, Yamanaka S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663&#8211;676.</td><td><a href=http://dx.doi.org/10.1016/j.cell.2006.07.024>10.1016/j.cell.2006.07.024</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19_3</td><td>BibArticle</td><td>Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861&#8211;872.</td><td><a href=http://dx.doi.org/10.1016/j.cell.2007.11.019>10.1016/j.cell.2007.11.019</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20_3</td><td>BibArticle</td><td>Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin, II, Thomsen JA. (2007). Induced pluripotent stem cell lines derived from human somatic cells. <Emphasis Type="Italic">Science</Emphasis>
                  <Emphasis Type="Bold">318</Emphasis>:1917&#8211;1920.</td><td><a href=http://dx.doi.org/10.1126/science.1151526>10.1126/science.1151526</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21_3</td><td>BibArticle</td><td>Zhao R, Daley GQ. (2008). From fibroblasts to iPS cells: induced pluripotency by defined factors. J Cell Biochem 105:949&#8211;955.</td><td><a href=http://dx.doi.org/10.1002/jcb.21871>10.1002/jcb.21871</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22_3</td><td>BibArticle</td><td>Cesnulevicius K, Timmer M, Wesemann M, Thomas T, Barkhausen T, Grothe C. (2006). Nucleofection is the most efficient nonviral transfection method for neuronal stem cells derived from ventral mesencephali with no changes in cell composition or dopaminergic fate. Stem Cells <Emphasis Type="Bold">24</Emphasis>:2776&#8211;91.</td><td><a href=http://dx.doi.org/10.1634/stemcells.2006-0176>10.1634/stemcells.2006-0176</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23_3</td><td>BibArticle</td><td>Anderson L, Burnstein RM, He X, Luce R, Furlong R, Foltynie T, Sykacek P, Menon DK, Caldwell MA. (2007). Gene expression changes in long term expanded human neural progenitor cells passaged by chopping lead to loss of neurogenic potential in vivo. Experiments in Neurology <Emphasis Type="Bold">204</Emphasis>:512&#8211;24.</td><td><a href=http://dx.doi.org/10.1016/j.expneurol.2006.12.025>10.1016/j.expneurol.2006.12.025</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24_3</td><td>BibArticle</td><td>Kim HJ, Sugimori M, Nakafuku M, Svendsen CN. (2007). Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurr1. Experiments in Neurology <Emphasis Type="Bold">203</Emphasis>:394&#8211;405.</td><td><a href=http://dx.doi.org/10.1016/j.expneurol.2006.08.029>10.1016/j.expneurol.2006.08.029</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25_3</td><td>BibArticle</td><td>Andersson E, Jensen JB, Parmar M, Guillemot F, Bjorklund A. (2006). Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2. Development <Emphasis Type="Bold">133</Emphasis>:507&#8211;16.</td><td><a href=http://dx.doi.org/10.1242/dev.02224>10.1242/dev.02224</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26_3</td><td>BibArticle</td><td>Zietlow R, Pekarik V, Armstrong RJ, Tyers P, Dunnett SB, Rosser AE. (2005). The survival of neural precursor cell grafts is influenced by in vitro expansion. Journal of Anatomy <Emphasis Type="Bold">207</Emphasis>:227&#8211;40.</td><td><a href=http://dx.doi.org/10.1111/j.1469-7580.2005.00449.x>10.1111/j.1469-7580.2005.00449.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27_3</td><td>BibArticle</td><td>Hagell P, Brundin P. (2001). Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. Journal of Neuropathology and Experimental Neurology <Emphasis Type="Bold">60</Emphasis>:741&#8211;52.</td><td><a href=http://dx.doi.org/10.1093/jnen/60.8.741>10.1093/jnen/60.8.741</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Year, Author_FamilyName_1, ArticleTitle, VolumeID, FirstPage</td><td>CrossRef</td></tr><tr><td>CR28_3</td><td>BibArticle</td><td>Olanow CW, Kordower JH, Freeman TB. (1996). Fetal nigral transplantation as a therapy for Parkinson&#8217;s disease. Trends in Neurosciences <Emphasis Type="Bold">19</Emphasis>:102&#8211;9.</td><td><a href=http://dx.doi.org/10.1016/S0166-2236(96)80038-5>10.1016/S0166-2236(96)80038-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29_3</td><td>BibArticle</td><td>Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchiel W, Kao R, Dillon S, Winfield H, Culver S, et al. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson&#8217;s disease. The New England Journal of Medicine <Emphasis Type="Bold">344</Emphasis>:710&#8211;19.</td><td><a href=http://dx.doi.org/10.1056/NEJM200103083441002>10.1056/NEJM200103083441002</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30_3</td><td>BibArticle</td><td>Freeman TB, Cicchetti F, Hauser RA, Deacon TW, Li XJ, Hersch SM, Nauert GM, Sanberg PR, Kordower JH, et al. (2000). Transplanted fetal striatum in Huntington&#8217;s disease: Phenotypic development and lack of pathology. Proceedings of the National Academy of Sciences <Emphasis Type="Bold">97</Emphasis>:13877&#8211;82.</td><td><a href=http://dx.doi.org/10.1073/pnas.97.25.13877>10.1073/pnas.97.25.13877</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31_3</td><td>BibArticle</td><td>Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, Leenders KL, Sawle G, Rothwell JC, et al. (1990). Grafts of fetal dopamine neurons survive and improve motor function in Parkinson&#8217;s disease. Science <Emphasis Type="Bold">247</Emphasis>:574&#8211;7.</td><td><a href=http://dx.doi.org/10.1126/science.2105529>10.1126/science.2105529</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32_3</td><td>BibArticle</td><td>Hagell P, Piccine P, Bj&#246;rklund A, Brundin P, Rehncrona S, Widner H, Crabb L, Pavese N, Oertel WH, et al. (2002). Dyskinesias following neural transplantation in Parkinson&#8217;s disease. Nature Neuroscience <Emphasis Type="Bold">5</Emphasis>:627&#8211;8.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR33_3</td><td>BibArticle</td><td>Bachoud-Levi AC, Gaura V, Brugieres P, Lefaucheur JP, Boisse MF, Maison P, Baudic S, Ribeiro MJ, Bourdet C, et al. (2006). Effect of fetal neural transplants in patients with Huntington&#8217;s disease 6 years after surgery: A long-term follow-up study. Lancet Neurology <Emphasis Type="Bold">5</Emphasis>:303&#8211;9.</td><td><a href=http://dx.doi.org/10.1016/S1474-4422(06)70381-7>10.1016/S1474-4422(06)70381-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34_3</td><td>BibArticle</td><td>Bachoud-Levi AC, Hantraye P, Peschanski M. (2002). Fetal neural grafts for Huntington&#8217;s disease: A prospective view. Movement Disorders <Emphasis Type="Bold">17</Emphasis>:439&#8211;44.</td><td><a href=http://dx.doi.org/10.1002/mds.10117>10.1002/mds.10117</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35_3</td><td>BibArticle</td><td>Hauser RA, Sandberg PR, Freeman TB, Stoessl AJ. (2002). Bilateral human fetal striatal transplantation in Huntington&#8217;s disease. Neurology <Emphasis Type="Bold">58</Emphasis>:687&#8211;685.</td><td><a href=http://dx.doi.org/10.1212/WNL.58.5.687>10.1212/WNL.58.5.687</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36_3</td><td>BibArticle</td><td>Freeman TB, Hauser RA, Sanberg PR, Saporta S. (2000). Neural transplantation for the treatment of Huntington&#8217;s disease. Progress in Brain Research <Emphasis Type="Bold">127</Emphasis>:405&#8211;11.</td><td><a href=http://dx.doi.org/10.1016/S0079-6123(00)27019-2>10.1016/S0079-6123(00)27019-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37_3</td><td>BibArticle</td><td>Kopyov OV, Jacques S, Eagle KS. (1998). Fetal transplantation for the treatment of neurodegenerative diseases &#8211; Current status and future potential. CNS Drugs <Emphasis Type="Bold">9</Emphasis>:77&#8211;83.</td><td><a href=http://dx.doi.org/10.2165/00023210-199809020-00001>10.2165/00023210-199809020-00001</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38_3</td><td>BibArticle</td><td>Rosser AE, Barker RA, Harrower T, Watts C, Farrington M, Ho AK, Burnstein RM, Menon DK, Gillard JH, et al. (2002). Unilateral transplantation of human primary fetal tissue in four patients with Huntington&#8217;s disease: NEST-UK safety report ISRCTN no 36485475. Journal of Neurology, Neurosurgery, and Psychiatry <Emphasis Type="Bold">73</Emphasis>:678&#8211;85.</td><td><a href=http://dx.doi.org/10.1136/jnnp.73.6.678>10.1136/jnnp.73.6.678</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39_3</td><td>BibArticle</td><td>Andrews PW, Damjanov I, Simon D, BantingGS, Carlin C, Dracopoli NC, Fogh J. (1984). Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Laboratory Investigation <Emphasis Type="Bold">50</Emphasis>:147&#8211;62.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR40_3</td><td>BibArticle</td><td>Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J, Decesare S, Jovin T, Zafonte R, et al. (2005). Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial. Journal of Neurosurg <Emphasis Type="Bold">103</Emphasis>:38&#8211;45.</td><td><a href=http://dx.doi.org/10.3171/jns.2005.103.1.0038>10.3171/jns.2005.103.1.0038</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41_3</td><td>BibArticle</td><td>Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J, Jannetta P, DeCesare S, Elder EM, et al. (2000). Transplantation of cultured human neuronal cellsfor patients with stroke. Neurology 22 <Emphasis Type="Bold">55</Emphasis>:565&#8211;9.</td><td><a href=http://dx.doi.org/10.1212/WNL.55.4.565>10.1212/WNL.55.4.565</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR42_3</td><td>BibArticle</td><td>Meltzer CC, Kondziolka D, Villemagne VL, Wechsler L, Goldstein S, Thulborn KR, Gebel J,Elder EM, DeCesare S, Jacobs A. (2001). Serial [18F] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke. Neurosurgery <Emphasis Type="Bold">49</Emphasis>:586&#8211;91; discussion 91&#8211;2.</td><td><a href=http://dx.doi.org/10.1227/00006123-200109000-00011>10.1227/00006123-200109000-00011</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Author_FamilyName_1, Year, FirstPage, VolumeID, JournalTitle</td><td>CrossRef</td></tr><tr><td>CR43_3</td><td>BibArticle</td><td>Nelson PT, Kondziolka D, Wechsler L, Goldstein S, Gebel J, DeCesare S, Elder EM, Zhang PJ, Jacobs A, et al. (2002). Clonal human (hNT) neuron grafts for stroke therapy: Neuropathology in a patient 27 months after implantation. The American Journal of Pathology <Emphasis Type="Bold">160</Emphasis>:1201&#8211;6.</td><td><a href=http://dx.doi.org/10.1016/S0002-9440(10)62546-1>10.1016/S0002-9440(10)62546-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR44_3</td><td>BibArticle</td><td>Bang OY, Lee JS, Lee PH, Lee G. (2005). Autologous mesenchymal stem cell transplantation in stroke patients. Annals of Neurology <Emphasis Type="Bold">57</Emphasis>:874&#8211;82.</td><td><a href=http://dx.doi.org/10.1002/ana.20501>10.1002/ana.20501</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>